₹1,473.30
-23.90 (-1.60%)
As of 18 Sept 2026, Haleos Labs Limited share price is ₹1,473.30. The stock opened at ₹1,473.30 and had closed at ₹1,497.20 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹1,100.60 and a high of ₹1,778.35. In terms of performance, Haleos Labs Limited share price has increased by 14.21% over the past six months and has increased by 23.24% over the last year.
HALEOSLABS Stock Price Chart
Haleos Labs Limited Overview
Market cap₹451 Crs
Volume2
Prev. Close₹1,497.20
Year range₹1,100.60 - ₹1,778.35
ISININE320X01016
About HALEOSLABS
SMS LifeSciences India is engaged in the business of manufacturing of Active Pharma Ingredients and their intermediates.
Haleos Labs Limited Historical Performance
1 Month Return-1.14%
6 Month Return16.93%
3 Year Return182.70%
3 Month Return6.32%
1 Year Return22.37%
5 Year Return102.93%
Haleos Labs Limited Fundamentals
ROCE(TTM)10.09%
P/E Ratio (TTM)28.47
P/B Ratio2.10
Debt to Equity0.44
ROE8.28%
EPS (TTM)52.45
Dividend Yield0.10%
Book Value709.74
Profit Margin5.47%
Operating Margin9.38%
Haleos Labs Limited Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 302.41 | 337.32 | 303.84 | 318.12 | 347.17 |
| EBITDA | 41.88 | 48.18 | 38.26 | 31.63 | 45.60 |
| Net Profit | 17.78 | 21.37 | 13.07 | 13.22 | 25.38 |
| EPS | 58.80 | 70.69 | 43.22 | 43.72 | 83.95 |
Haleos Labs Limited Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 1,491.30 |
| Resistance 1 (R1) | 1,509.00 |
| Pivot Point | 1,503.10 |
Haleos Labs Limited Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 24-Sep-2025 | 29-May-2025 | 24-Sep-2025 | Final | ₹1.50 |
| 23-Sep-2024 | 27-May-2024 | 23-Sep-2024 | Final | ₹1.50 |
| 22-Sep-2023 | 29-May-2023 | 23-Sep-2023 | Final | ₹1.50 |
| 22-Sep-2022 | 28-May-2022 | 24-Sep-2022 | Final | ₹1.50 |
| 20-Sep-2021 | 18-Jun-2021 | 21-Sep-2021 | Final | ₹1.50 |
HALEOSLABS Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| T V V S N Murthy | Managing Director |
| Talluri Venkata Praveen | Executive Directorector |
| Sudeepthi Gopineedi | WTD & Executive Directorector |
Haleos Labs Limited Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,867.30+0.74% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,323.00+1.80% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,875.00+1.30% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Haleos Labs Limited today is ₹1,473.30 on NSE and ₹1,473.30 on BSE.
- The 52-week high of Haleos Labs Limited is ₹1,778.35, while the 52-week low is ₹1,100.60.
- The current market capitalisation of Haleos Labs Limited is approximately ₹451 crore.
- The P/E (Price-to-Earnings) ratio of Haleos Labs Limited is 18.69. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Haleos Labs Limited is 1.90. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Haleos Labs Limited shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for HALEOSLABS on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Haleos Labs Limited has delivered a return of approximately 182.70%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Haleos Labs Limited comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 72.11% promoters, 0.00% FIIs, 0.31% DIIs, and 23.99% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
